Determinants of HIV-1 broadly neutralizing antibody induction P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ... Nature medicine 22 (11), 1260-1267, 2016 | 177 | 2016 |
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study B Hasse, B Ledergerber, B Hirschel, P Vernazza, TR Glass, A Jeannin, ... Clinical infectious diseases 51 (11), 1314-1322, 2010 | 119 | 2010 |
A smoking cessation programme in HIV-infected individuals: a pilot study Swiss HIV Cohort Study, L Elzi, D Spoerl, J Voggensperger, D Nicca, ... Antiviral therapy 11 (6), 787-796, 2006 | 95 | 2006 |
Assessing the paradox between transmitted and acquired HIV type 1 drug resistance mutations in the Swiss HIV Cohort Study from 1998 to 2012 WL Yang, R Kouyos, AU Scherrer, J Böni, C Shah, S Yerly, T Klimkait, ... The Journal of infectious diseases 212 (1), 28-38, 2015 | 85 | 2015 |
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality TR Glass, JAC Sterne, MP Schneider, S De Geest, D Nicca, H Furrer, ... Aids 29 (16), 2195-2200, 2015 | 82 | 2015 |
Reasons why nurses decline influenza vaccination: a qualitative study A Pless, SR McLennan, D Nicca, DM Shaw, BS Elger BMC nursing 16, 1-7, 2017 | 81 | 2017 |
Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000–2016: a systematic review and meta-analysis V Ghisla, AU Scherrer, D Nicca, DL Braun, JS Fehr Infection 45, 309-321, 2017 | 77 | 2017 |
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study V von Wyl, T Klimkait, S Yerly, D Nicca, H Furrer, M Cavassini, A Calmy, ... PloS one 8 (10), e77691, 2013 | 75 | 2013 |
Emergence of acquired HIV-1 drug resistance almost stopped in Switzerland: a 15-year prospective cohort analysis AU Scherrer, V von Wyl, WL Yang, RD Kouyos, J Böni, S Yerly, T Klimkait, ... Clinical infectious diseases 62 (10), 1310-1317, 2016 | 72 | 2016 |
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017 B Hampel, K Kusejko, RD Kouyos, J Böni, M Flepp, M Stöckle, A Conen, ... HIV medicine 21 (4), 228-239, 2020 | 70 | 2020 |
HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV Cohort Study A Marzel, M Shilaih, WL Yang, J Böni, S Yerly, T Klimkait, V Aubert, ... Clinical Infectious Diseases 62 (1), 115-122, 2016 | 64 | 2016 |
A treatment-as-prevention trial to eliminate hepatitis C among men who have sex with men living with human immunodeficiency virus (HIV) in the Swiss HIV Cohort Study DL Braun, B Hampel, B Ledergerber, C Grube, H Nguyen, ... Clinical infectious diseases 73 (7), e2194-e2202, 2021 | 61 | 2021 |
A highly virulent variant of HIV-1 circulating in the Netherlands C Wymant, D Bezemer, F Blanquart, L Ferretti, A Gall, M Hall, T Golubchik, ... Science 375 (6580), 540-545, 2022 | 56 | 2022 |
HIV-positive-to-HIV-positive liver transplantation A Calmy, C Van Delden, E Giostra, C Junet, LR Brandt, S Yerly, JP Chave, ... American journal of transplantation 16 (8), 2473-2478, 2016 | 47 | 2016 |
Outcome of smoking cessation counselling of HIV‐positive persons by HIV care physicians M Huber, B Ledergerber, R Sauter, J Young, J Fehr, A Cusini, M Battegay, ... HIV medicine 13 (7), 387-397, 2012 | 47 | 2012 |
Dually active HIV/HBV antiretrovirals as protection against incident hepatitis B infections: potential for prophylaxis M Shilaih, A Marzel, AU Scherrer, DL Braun, H Kovari, M Rougemont, ... The Journal of infectious diseases 214 (4), 599-606, 2016 | 44 | 2016 |
Mortality from suicide among people living with HIV and the general Swiss population: 1988‐2017 Y Ruffieux, L Lemsalu, K Aebi‐Popp, A Calmy, M Cavassini, CA Fux, ... Journal of the International AIDS Society 22 (8), e25339, 2019 | 43 | 2019 |
High cure rates with grazoprevir-elbasvir with or without ribavirin guided by genotypic resistance testing among human immunodeficiency virus/hepatitis C virus–coinfected men … DL Braun, B Hampel, R Kouyos, H Nguyen, C Shah, M Flepp, M Stöckle, ... Clinical infectious diseases 68 (4), 569-576, 2019 | 42 | 2019 |
Successful prevention of transmission of integrase resistance in the Swiss HIV Cohort Study AU Scherrer, WL Yang, RD Kouyos, J Böni, S Yerly, T Klimkait, V Aubert, ... The Journal of infectious diseases 214 (3), 399-402, 2016 | 42 | 2016 |
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy TR Glass, M Rotger, A Telenti, L Decosterd, C Csajka, HC Bucher, ... PloS one 7 (1), e29186, 2012 | 36 | 2012 |